Zentalis Pharmaceuticals's total assets for Q4 2024 were $430.34M, a decrease of -4.51% from the previous quarter. ZNTL total liabilities were $93.15M for the fiscal quarter, a -3.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.